AR053088A1 - Forma cristalina de un derivado de piridazinona. proceso de obtencion y formulaciones farmaceuticas. - Google Patents

Forma cristalina de un derivado de piridazinona. proceso de obtencion y formulaciones farmaceuticas.

Info

Publication number
AR053088A1
AR053088A1 ARP050102925A ARP050102925A AR053088A1 AR 053088 A1 AR053088 A1 AR 053088A1 AR P050102925 A ARP050102925 A AR P050102925A AR P050102925 A ARP050102925 A AR P050102925A AR 053088 A1 AR053088 A1 AR 053088A1
Authority
AR
Argentina
Prior art keywords
obtaining
piridazinona
derivative
crystal form
pharmaceutical formulations
Prior art date
Application number
ARP050102925A
Other languages
English (en)
Spanish (es)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR053088A1 publication Critical patent/AR053088A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP050102925A 2004-07-16 2005-07-14 Forma cristalina de un derivado de piridazinona. proceso de obtencion y formulaciones farmaceuticas. AR053088A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58854304P 2004-07-16 2004-07-16

Publications (1)

Publication Number Publication Date
AR053088A1 true AR053088A1 (es) 2007-04-25

Family

ID=35004166

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050102925A AR053088A1 (es) 2004-07-16 2005-07-14 Forma cristalina de un derivado de piridazinona. proceso de obtencion y formulaciones farmaceuticas.

Country Status (16)

Country Link
US (1) US7655656B2 (enExample)
EP (1) EP1773820A1 (enExample)
JP (1) JP2008506682A (enExample)
KR (1) KR100843862B1 (enExample)
CN (1) CN1984650A (enExample)
AR (1) AR053088A1 (enExample)
AU (1) AU2005264065A1 (enExample)
BR (1) BRPI0512708A (enExample)
CA (1) CA2573718A1 (enExample)
IL (1) IL180425A0 (enExample)
MX (1) MX2007000625A (enExample)
NO (1) NO20070701L (enExample)
RU (1) RU2342384C2 (enExample)
TW (1) TW200612904A (enExample)
WO (1) WO2006008641A1 (enExample)
ZA (1) ZA200610702B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0487425A (ja) * 1990-07-31 1992-03-19 Fujitsu Ltd 回線切り替え装置
CN102459170B (zh) * 2009-04-09 2014-07-23 桑多斯股份公司 沙格列汀的结晶形式
TWI516272B (zh) 2013-06-05 2016-01-11 財團法人工業技術研究院 應用於生髮之方法及醫藥組成物
US9402876B2 (en) 2013-11-27 2016-08-02 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
KR102166453B1 (ko) 2020-02-03 2020-10-15 중앙대학교 산학협력단 Hapln1을 포함하는 폐질환 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985792A (en) * 1971-12-23 1976-10-12 Alexander Galat Stable sodium acetylsalicylate and method for its manufacture
US3751439A (en) * 1972-02-24 1973-08-07 Hercules Inc Crystalline nickel chelate of 1-nitroso-2-naphthol and process for producing same
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
CN100337624C (zh) 2002-11-12 2007-09-19 沃纳-兰伯特公司 使用苯并吡喃类化合物促进毛发生长的方法
CA2555741C (en) * 2004-02-12 2010-03-23 Warner-Lambert Company Llc Method of stimulating hair growth

Also Published As

Publication number Publication date
WO2006008641A1 (en) 2006-01-26
CA2573718A1 (en) 2006-01-26
TW200612904A (en) 2006-05-01
RU2007101376A (ru) 2008-07-20
CN1984650A (zh) 2007-06-20
BRPI0512708A (pt) 2008-04-01
MX2007000625A (es) 2007-03-07
KR20070054178A (ko) 2007-05-28
IL180425A0 (en) 2008-03-20
ZA200610702B (en) 2008-07-30
EP1773820A1 (en) 2007-04-18
US7655656B2 (en) 2010-02-02
KR100843862B1 (ko) 2008-07-04
WO2006008641A8 (en) 2006-05-04
RU2342384C2 (ru) 2008-12-27
NO20070701L (no) 2007-02-07
AU2005264065A1 (en) 2006-01-26
US20080318967A1 (en) 2008-12-25
JP2008506682A (ja) 2008-03-06

Similar Documents

Publication Publication Date Title
AR051190A1 (es) Formulacion para estimular el crecimiento de pelo
MY159522A (en) Administration of dipeptidyl peptidase inhibitors
HRP20110094T8 (en) Solid preparation comprising alogliptin and pioglitazone
GEP20115171B (en) Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
WO2007120647A3 (en) Compositions useful as inhibitors of voltage-gated sodium channels
WO2007135527A3 (en) Benzimidazolyl compounds
WO2006072393A3 (de) Sulfonylpyrrolidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2007079199A3 (en) Substituted bis-amide metalloprotease inhibitors
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
MA30725B1 (fr) Administration d'inhibiteurs de la dipeptidyl peptidase
MX367154B (es) Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico.
IS2545B (is) 4-anílínó-7-((píperídín-4-ýl)oxý) kínasólínafleiður
TW200744602A (en) Administration of dipeptidyl peptidase inhibitors
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2008005569A3 (en) Modulators of metabolism and the treatment of disorders related thereto
NO20051260L (no) Arylsubstituerte diazabicykloalkaner som nikotinacetylcholinagonister
NO20070445L (no) Pyrimidinderivater.
MX2007014892A (es) Formas polimorficas del ester etilico del acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}- 1-metil-h-bencimidazol-5-carbonil)-piridin-2-il--amino]propionico .
WO2006011050A3 (en) Pyridine derivatives
WO2007084914A3 (en) Phenoxy-substituted pyrimidines as adenosine receptor antagonists
UA101313C2 (uk) Щотижневе введення інгібіторів дипептидилпептидази
WO2005070884A3 (en) Heterocyclic compounds useful as growth hormone secretagogues
WO2005105821A3 (en) Process for the preparation of telithromycin
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
AR053088A1 (es) Forma cristalina de un derivado de piridazinona. proceso de obtencion y formulaciones farmaceuticas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal